TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Teva Pharmaceutical Industries Ltd quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2010 to Q2 2024.
  • Teva Pharmaceutical Industries Ltd Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 1.13B shares, a 1.16% increase year-over-year.
  • Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.12B shares, a 0.81% increase from 2022.
  • Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.11B shares, a 0.27% increase from 2021.
  • Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.11B shares, a 1.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 1.13B +13M +1.16% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 1.12B +8M +0.72% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 1.12B +9M +0.81% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-12
Q3 2023 1.14B +16M +1.43% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.12B +10M +0.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 1.12B +8M +0.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 1.11B +3M +0.27% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-12
Q3 2022 1.12B +10M +0.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.11B +1M +0.09% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 1.11B 0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 1.11B +12M +1.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-12
Q3 2021 1.11B +13M +1.19% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 1.11B +9M +0.82% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 1.11B +11M +1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 1.1B +4M +0.37% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-10
Q3 2020 1.1B +4M +0.37% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 1.1B +8M +0.73% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 1.1B +6M +0.55% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 1.09B +70M +6.86% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 1.09B +74M +7.27% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 1.09B +74M +7.27% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 1.09B +70M +6.86% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 1.02B +5M +0.49% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-10
Q3 2018 1.02B +1M +0.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 1.02B +1M +0.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 1.02B +3M +0.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 1.02B +55M +5.72% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 1.02B +33M +3.35% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 1.02B +97M +10.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 1.02B +97M +10.5% Jan 1, 2017 Mar 31, 2017 6-K 2017-05-11
Q4 2016 961M +97M +11.2% Oct 1, 2016 Dec 31, 2016 20-F 2017-02-15
Q3 2016 984M +122M +14.2% Jul 1, 2016 Sep 30, 2016 6-K 2017-11-02
Q2 2016 920M +61M +7.1% Apr 1, 2016 Jun 30, 2016 6-K 2017-08-03
Q1 2016 920M +61M +7.1% Jan 1, 2016 Mar 31, 2016 6-K 2017-05-11
Q4 2015 864M +6M +0.7% Oct 1, 2015 Dec 31, 2015 20-F 2017-02-15
Q3 2015 862M +1M +0.12% Jul 1, 2015 Sep 30, 2015 6-K 2016-11-15
Q2 2015 859M +2M +0.23% Apr 1, 2015 Jun 30, 2015 6-K 2016-08-04
Q1 2015 859M +7M +0.82% Jan 1, 2015 Mar 31, 2015 6-K 2016-05-09
Q4 2014 858M +8M +0.94% Oct 1, 2014 Dec 31, 2014 20-F 2017-02-15
Q3 2014 861M +15M +1.77% Jul 1, 2014 Sep 30, 2014 6-K 2015-10-29
Q2 2014 857M +8M +0.94% Apr 1, 2014 Jun 30, 2014 6-K 2015-07-30
Q1 2014 852M -4M -0.47% Jan 1, 2014 Mar 31, 2014 6-K 2015-04-30
Q4 2013 850M -23M -2.64% Oct 1, 2013 Dec 31, 2013 20-F 2016-02-11
Q3 2013 846M -23M -2.65% Jul 1, 2013 Sep 30, 2013 6-K 2014-10-30
Q2 2013 849M -24M -2.75% Apr 1, 2013 Jun 30, 2013 6-K 2014-07-31
Q1 2013 856M -26M -2.95% Jan 1, 2013 Mar 31, 2013 6-K 2014-05-02
Q4 2012 873M -20M -2.24% Oct 1, 2012 Dec 31, 2012 20-F 2015-02-09
Q3 2012 869M -21M -2.36% Jul 1, 2012 Sep 30, 2012 6-K 2013-10-31
Q2 2012 873M -23M -2.57% Apr 1, 2012 Jun 30, 2012 6-K 2013-08-01
Q1 2012 882M -20M -2.22% Jan 1, 2012 Mar 31, 2012 6-K 2013-05-02
Q4 2011 893M -28M -3.04% Oct 1, 2011 Dec 31, 2011 20-F 2014-02-10
Q3 2011 890M -31M -3.37% Jul 1, 2011 Sep 30, 2011 6-K 2012-11-01
Q2 2011 896M -25M -2.71% Apr 1, 2011 Jun 30, 2011 6-K 2012-08-02
Q1 2011 902M -19M -2.06% Jan 1, 2011 Mar 31, 2011 6-K 2012-05-09
Q4 2010 921M Oct 1, 2010 Dec 31, 2010 20-F 2013-02-12
Q3 2010 921M Jul 1, 2010 Sep 30, 2010 6-K 2011-11-02
Q2 2010 921M Apr 1, 2010 Jun 30, 2010 6-K 2011-07-28
Q1 2010 921M Jan 1, 2010 Mar 31, 2010 6-K 2011-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.